Reduced MIM expression in tumor cells may pathologically impinge on the response of these cells to tumor microenvironments by favoring migration toward higher concentrations of growth factors released from other sources where pathogenesis arises, and thereby facilitating tumor cells to travel to distant sites. The gene discussed is MTSS1; the disease is neoplasm.